Rekha Hemrajani

Rekha Hemrajani is the founder of Ravinia Consulting, Inc. Current jobs include Independent Non-Executive Director at MaxCyte, Inc. since 2021, Independent Director at BioAge Labs, Inc. since 2021, Director at ALX Oncology, Inc. since 2020, Director & Partner at Hemmo Pharmaceuticals Pvt Ltd., Non-Executive Independent Director at ALX Oncology Holdings, Inc. since 2020, Director & Partner at Hemmo Pharma LLP, and Director at LB Pharmaceuticals, Inc. starting in 2025.
Former jobs include President, Chief Executive Officer & Director at Aravive, Inc. in 2020, Chief Executive Officer & Director at Jiya Acquisition Corp.
from 2020 to 2022, Independent Director at Adverum Biotechnologies, Inc. from 2019 to 2021, Vice President at Lehman Brothers, Inc., VP & Head-Licensing, Mergers & Acquisitions at Onyx Pharmaceuticals, Inc. from 2012 to 2013, Vice President-Business Development at Exelixis, Inc. from 2003 to 2011, CFO, SVP-Business & Financial Operations at Sagimet Biosciences, Inc. from 2015 to 2016, Chief Operating Officer at Rapt Therapeutics, Inc. from 2016 to 2019, and Chief Operating & Financial Officer at Arcus Biosciences, Inc. in 2019.
Education includes undergraduate studies at the University of Michigan and an MBA from Kellogg School of Management.